This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nesterov, A. Articles by Kraft, A. S. Search for Related Content PubMed PubMed Citation Articles by Nesterov, A. Articles by Kraft, A. S.

Oncogenic Ras Sensitizes Normal Human Cells to Tumor Necrosis Factor--Related Apoptosis-Inducing Ligand-Induced Apoptosis

Division of Medical Oncology, University of Colorado Health Sciences Center, Denver, Colorado

Tumor necrosis factor--related apoptosis-inducing ligand (TRAIL) is a cytotoxic cytokine that induces apoptosis in tumor cells but rarely kills normal ones. To determine how normal human cells acquire TRAIL-sensitive phenotype during the process of malignant transformation, we used an experimental system that allows for controlled conversion of human cells from normal to cancerous by introduction of several genes. Human embryonic kidney cells and foreskin fibroblasts were first immortalized by combination of the early region of simian virus 40 and telomerase and then were transformed with oncogenic Ras. Both normal and immortalized cells were resistant to TRAIL-induced apoptosis, whereas Ras-transformed cells were susceptible. Ras transformation enhanced TRAIL-induced activation of caspase 8 by increasing its recruitment to TRAIL receptors. The proapoptotic effects of Ras could be reversed by mutations in its effector loop or by inhibitors of either farnesyl transferase or mitogen-activated protein kinase kinase. The expression of constitutively activated mitogen-activated protein kinase kinase 1 enhanced caspase 8 recruitment and sensitized immortalized human embryonic kidney cells to TRAIL-induced death. These results indicate that in normal human cells the TRAIL-induced apoptotic signal is blocked at the level of caspase 8 recruitment and that this block can be eliminated by Ras transformation, involving activation of the mitogen-activated protein kinase pathway.

This article has been cited by other articles:

				A. Ashkenazi, P. Holland, and S. G. Eckhardt Ligand-Based Targeting of Apoptosis in Cancer: The Potential of Recombinant Human Apoptosis Ligand 2/Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (rhApo2L/TRAIL) J. Clin. Oncol., July 20, 2008; 26(21): 3621 - 3630. [Abstract] [Full Text] [PDF]

				A. Panner, J. L. Nakamura, A. T. Parsa, P. Rodriguez-Viciana, M. S. Berger, D. Stokoe, and R. O. Pieper mTOR-Independent Translational Control of the Extrinsic Cell Death Pathway by RalA Mol. Cell. Biol., October 15, 2006; 26(20): 7345 - 7357. [Abstract] [Full Text] [PDF]

				M. Jalving, S. de Jong, J. J. Koornstra, W. Boersma-van Ek, N. Zwart, J. Wesseling, E. G.E. de Vries, and J. H. Kleibeuker TRAIL Induces Apoptosis in Human Colorectal Adenoma Cell Lines and Human Colorectal Adenomas. Clin. Cancer Res., July 15, 2006; 12(14): 4350 - 4356. [Abstract] [Full Text] [PDF]

				F. Teraishi, W. Guo, L. Zhang, F. Dong, J. J. Davis, T. Sasazuki, S. Shirasawa, J. Liu, and B. Fang Activation of Sterile20-Like Kinase 1 in Proteasome Inhibitor Bortezomib-Induced Apoptosis in Oncogenic K-ras-Transformed Cells. Cancer Res., June 15, 2006; 66(12): 6072 - 6079. [Abstract] [Full Text] [PDF]

				N. Smakman, D. J. M. van den Wollenberg, I. H. M. B. Rinkes, R. C. Hoeben, and O. Kranenburg Sensitization to Apoptosis Underlies KrasD12-Dependent Oncolysis of Murine C26 Colorectal Carcinoma Cells by Reovirus T3D J. Virol., December 1, 2005; 79(23): 14981 - 14985. [Abstract] [Full Text] [PDF]

				K. G. Drosopoulos, M. L. Roberts, L. Cermak, T. Sasazuki, S. Shirasawa, L. Andera, and A. Pintzas Transformation by Oncogenic RAS Sensitizes Human Colon Cells to TRAIL-induced Apoptosis by Up-regulating Death Receptor 4 and Death Receptor 5 through a MEK-dependent Pathway J. Biol. Chem., June 17, 2005; 280(24): 22856 - 22867. [Abstract] [Full Text] [PDF]

				H. Cui, T. Li, and H.-F. Ding Linking of N-Myc to Death Receptor Machinery in Neuroblastoma Cells J. Biol. Chem., March 11, 2005; 280(10): 9474 - 9481. [Abstract] [Full Text] [PDF]

				Y. Wang, K. C. Quon, D. A. Knee, A. Nesterov, and A. S. Kraft RAS, MYC, and Sensitivity to Tumor Necrosis Factor-{alpha}-Related Apoptosis-Inducing Ligand-Induced Apoptosis Cancer Res., February 15, 2005; 65(4): 1615 - 1617. [Full Text] [PDF]